1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
9th Invest in ME International ME Conference, 2014 - Part 2: Pathogens and the Gut
Mark Berry continues his series of articles on the 9th Invest in ME International ME Conference in London, with the emphasis shifting from autoimmunity to pathogens and the gut ...
Discuss the article on the Forums.

F.D.A. Approves Vaccine to Fight Prostate Cancer

Discussion in 'Other Health News and Research' started by jace, Apr 30, 2010.

  1. jace

    jace Off the fence

    Messages:
    855
    Likes:
    170
    England
    New Prostate Cancer immune booster drug approved

    An immune system booster was approved by the FDA yesterday -
    http://www.latimes.com/news/la-sci-prostate-20100429,0,1411702.story?track=rss&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+latimes%2Fnews%2Fscience+%28L.A.+Times+-+Science%29

    The first couple of paragraphs:
    Aggressive prostate cancer is linked to XMRV ...
     
  2. Jerry S

    Jerry S Senior Member

    Messages:
    422
    Likes:
    13
    Chicago
  3. Andrew

    Andrew Senior Member

    Messages:
    1,977
    Likes:
    1,267
    Los Angeles, USA
    Very interesting. Thanks for posting.

    I wonder now what to do if one has CFS and prostate cancer, considering that vaccinations can make us sicker.

    Another thought: I wonder if this has any affect on XMRV.
     
  4. JillBohr

    JillBohr Senior Member

    Messages:
    247
    Likes:
    0
    Columbus, OH
    Why did the FDA reject this drug in 2007?
     
  5. acer2000

    acer2000 Senior Member

    Messages:
    613
    Likes:
    268
    Somewhat related... due to XMRV being a potential cause of prostate cancer.
    ----

    The Food and Drug Administration on Thursday approved the first treatment that uses a so-called cancer vaccine, a drug that trains the bodys own immune system to fight the disease.

    The drug, Provenge, developed by the Dendreon Corporation, was approved to treat advanced prostate cancer. In clinical trials it extended the lives of patients about four months compared with a placebo.

    http://www.nytimes.com/2010/04/30/health/30drug.html?ref=health
     
  6. consuegra

    consuegra Senior Member

    Messages:
    102
    Likes:
    32
    Provenge has a checkered history. There is something to be learned in reading about its history - and what is learned is not all good. In 2007 it was approved by an FDA advisory committee by a 13-4 vote. The FDA usually follows these expert panels recommendations, but, astonishingly, in this case, they did not. Amongst the 4 negative votes were two "movers and shakers" (big shots). The FDA sent Provenge back to trials and after another two years, the drug delivered the same level of results (essentially repeating the same trials) and remarkably it was finally approved. How many men did of prostate cancer over these additional two years is anyone's guess. Provenge looks like a remarkable drug, but it had the usual stiff resistance from some quarters. Its approval opens the door for additional drugs of this category.

    Chrishttp://cfspatientadvocate.blogspot.com
     
  7. SpecialK82

    SpecialK82 Senior Member

    Messages:
    897
    Likes:
    475
    USA
    Does anyone understand the science behind why a vaccine for prostate cancer helps to fight prostate cancer when a person already has the cancer in their body?

    I know I had read somewhere that a development of a vaccine for XMRV could potentially help fight XMRV in a person already infected - I didn't realize vaccines could work this way...

    Kristina
     

See more popular forum discussions.

Share This Page